Alpha Profiles · Company Profile
Amphastar Pharmaceuticals, Inc.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/amphastar-pharmaceuticals-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: AMPH
- Verification
- Partially verified
- Last reviewed
- 2026-10-18T07:12:02.527648+00:00
Overview
Alpha's canonical identity and public leadership record for Amphastar Pharmaceuticals, Inc..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
7 public recordsChief Executive Officer, President, Chief Scientific Officer and Director
- State
- confirmed
- Effective
- From Apr 13, 2026
- Confidence
- 94%
- Evidence
- AMPH DEF 14A executive officersApr 13, 2026
Chief Executive Officer, President, Chief Scientific Officer and Director
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- AMPH executive roster sourceMay 3, 2026
Executive Vice President of Sales and Marketing and Corporate Administration Center, President of Amphastar France Pharmaceuticals, S.A.S., Corporate Secretary and Director
- State
- confirmed
- Effective
- From Apr 13, 2026
- Confidence
- 94%
- Evidence
- AMPH DEF 14A executive officersApr 13, 2026
Chief Operating Officer, Chief Scientist and Chairman of the Board of Directors
- State
- confirmed
- Effective
- From Apr 13, 2026
- Confidence
- 94%
- Evidence
- AMPH DEF 14A executive officersApr 13, 2026
Chief Operating Officer, Chief Scientist and Chairman of the Board of Directors
- State
- confirmed
- Effective
- Date not stated
- Confidence
- 94%
- Evidence
- AMPH executive roster sourceMay 3, 2026
Senior Executive Vice President of Production Center; Executive Vice President of Scientific Affairs and President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
- State
- confirmed
- Effective
- From Apr 13, 2026
- Confidence
- 94%
- Evidence
- AMPH DEF 14A executive officersApr 13, 2026
Chief Financial Officer, Executive Vice President of Finance, and Treasurer; President of International Medication Systems, Limited and Director
- State
- confirmed
- Effective
- From Apr 13, 2026
- Confidence
- 94%
- Evidence
- AMPH DEF 14A executive officersApr 13, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 18, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
11 public records- State
- confirmed
- Effective
- From Jan 1, 2025
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 2019
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 2004
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 2021
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 2008
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 1996
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 1996
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 2005
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 2002
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 85%
- Evidence
- Amphastar Pharmaceuticals, Inc. DEF 14A 2026-04-13Apr 13, 2026
Committees
3 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
Audit
- Chair
- Gayle Deflin
- Members
- Gayle Deflin (Chair); Hsin-Liang Lee
Compensation
- Chair
- Richard Prins
- Members
- Richard Prins (Chair); David Gaugh; Floyd F. Petersen; Michael A. Zasloff
Nominating and Governance
- Chair
- Diane G. Gerst
- Members
- Diane G. Gerst (Chair); Hsin-Liang Lee; Michael A. Zasloff
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-18T07:12:02.527648+00:00